Internal Medicine Associates

Danville, Virginia 25451

0 studies enrolling now · 5 studies all time

What they study most

Crohn's Disease, Irritable Bowel Syndrome, Ulcerative Colitis

Studies at this site

• Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome — Completed
• Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease — Completed
• A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease — Completed
• FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis — Completed
• Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease — Completed